Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-07-08
DOI
10.3389/fendo.2014.00110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
- (2018) Chih-Cheng Hsu et al. JOURNAL OF ALZHEIMERS DISEASE
- Type 2 Diabetic and Alzheimer's Disease Mice Present Similar Behavioral, Cognitive, and Vascular Anomalies
- (2018) Cristina Carvalho et al. JOURNAL OF ALZHEIMERS DISEASE
- Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
- (2018) Tze Pin Ng et al. JOURNAL OF ALZHEIMERS DISEASE
- Type II Diabetes in Mild Cognitive Impairment and Alzheimer's Disease: Results from a Prospective Population-Based Study in Germany
- (2017) Pablo Toro et al. JOURNAL OF ALZHEIMERS DISEASE
- An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's Disease
- (2017) Paula I. Moreira et al. JOURNAL OF ALZHEIMERS DISEASE
- Incretin-Modulated Beta Cell Energetics in Intact Islets of Langerhans
- (2014) David J. Hodson et al. MOLECULAR ENDOCRINOLOGY
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats
- (2014) H.-Y. Cai et al. NEUROSCIENCE
- Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose
- (2013) Melissa A. Burmeister et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
- (2013) A.I. Duarte et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mitochondrial Abnormalities in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease
- (2013) Sonia C. Correia et al. Current Alzheimer Research
- Advances in Pharmacologic Therapies for Type 2 Diabetes
- (2013) Linde M. Morsink et al. Current Atherosclerosis Reports
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
- (2013) E. M. Moore et al. DIABETES CARE
- Neuroprotective Effects of Liraglutide for Stroke Model of Rats
- (2013) Kenichiro Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats
- (2013) Hiranya Pintana et al. JOURNAL OF ENDOCRINOLOGY
- The role of FOXO1 in β-cell failure and type 2 diabetes mellitus
- (2013) Tadahiro Kitamura Nature Reviews Endocrinology
- Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis
- (2013) A. Cignarelli et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
- (2012) Kerry Hunter et al. BMC NEUROSCIENCE
- Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation
- (2012) Sónia C. Correia et al. BRAIN RESEARCH
- Metabolic Alterations Induced by Sucrose Intake and Alzheimer’s Disease Promote Similar Brain Mitochondrial Abnormalities
- (2012) Cristina Carvalho et al. DIABETES
- Metformin-Induced Hepatotoxicity
- (2012) F. Miralles-Linares et al. DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis
- (2012) C. F. Deacon et al. DIABETES OBESITY & METABOLISM
- GLP-1 based therapies: differential effects on fasting and postprandial glucose
- (2012) M.S. Fineman et al. DIABETES OBESITY & METABOLISM
- Dipeptidylpeptidase-IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats
- (2012) E. Tarantola et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- An update on type 2 diabetes, vascular dementia and Alzheimer's disease
- (2012) L.G. Exalto et al. EXPERIMENTAL GERONTOLOGY
- Glucagon-Like Peptide-1 Decreases Intracerebral Glucose Content by Activating Hexokinase and Changing Glucose Clearance during Hyperglycemia
- (2012) Michael Gejl et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats
- (2012) Wei-Na Han et al. NEUROBIOLOGY OF AGING
- Insulin-induced recurrent hypoglycemia exacerbates diabetic brain mitochondrial dysfunction and oxidative imbalance
- (2012) Susana Cardoso et al. NEUROBIOLOGY OF DISEASE
- The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease
- (2012) Caitriona M. Long-Smith et al. NEUROMOLECULAR MEDICINE
- Roles of AMP-activated Protein Kinase in Alzheimer’s Disease
- (2012) Zhiyou Cai et al. NEUROMOLECULAR MEDICINE
- Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
- (2012) Jiejie Li et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Insulin resistance in the nervous system
- (2012) Bhumsoo Kim et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer’s disease by exendin-4
- (2011) Song Chen et al. AGE
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Understanding the benefit of metformin use in cancer treatment
- (2011) Ryan JO Dowling et al. BMC Medicine
- Clarifying the Role of Incretin-Based Therapies in the Treatment of Type 2 Diabetes Mellitus
- (2011) R. Keith Campbell CLINICAL THERAPEUTICS
- Glucagon-like Peptide–1 Analogues for Type 2 Diabetes Mellitus
- (2011) Baptist Gallwitz DRUGS
- Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease
- (2011) Tz-Chuen Ju et al. JOURNAL OF CELL BIOLOGY
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Management of type 2 diabetes: new and future developments in treatment
- (2011) Abd A Tahrani et al. LANCET
- Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes
- (2011) Amit Gupta et al. NEUROPHARMACOLOGY
- Mechanisms of metformin action on glucose transport and metabolism in human adipocytes
- (2010) Jean Grisouard et al. BIOCHEMICAL PHARMACOLOGY
- Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia
- (2010) Susana Cardoso et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
- (2010) C. F. Deacon DIABETES OBESITY & METABOLISM
- Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials
- (2010) C. Lamanna et al. DIABETES OBESITY & METABOLISM
- Regulation of mitochondrial biogenesis
- (2010) François R. Jornayvaz et al. Essays in Biochemistry
- The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test
- (2010) Ruben Isacson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of AMP-Activated Protein Kinase in Cerebral Ischemia
- (2010) Jun Li et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- How does diabetes accelerate Alzheimer disease pathology?
- (2010) Catrina Sims-Robinson et al. Nature Reviews Neurology
- Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
- (2010) E. Kickstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes
- (2010) Ulrich Werner et al. REGULATORY PEPTIDES
- Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters
- (2010) Susana Cardoso et al. SYNAPSE
- A review of exenatide as adjunctive therapy in patients with type 2 diabetes
- (2010) Gisela Robles Drug Design Development and Therapy
- Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
- (2009) Paula I. Moreira et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects
- (2009) M. A. Bush et al. DIABETES OBESITY & METABOLISM
- Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer’s prone mice
- (2009) Michele D’Amico et al. EXPERIMENTAL GERONTOLOGY
- AMPK in the brain: its roles in energy balance and neuroprotection
- (2009) Gabriele V. Ronnett et al. JOURNAL OF NEUROCHEMISTRY
- Glucagon-Like Peptide-1 Induced Signaling and Insulin Secretion Do Not Drive Fuel and Energy Metabolism in Primary Rodent Pancreatic β-Cells
- (2009) Marie-Line Peyot et al. PLoS One
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
- (2009) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
- (2009) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- (Pre)diabetes, brain aging, and cognition
- (2008) Jarbas S. Roriz-Filho et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Insulin Resistance and Alzheimers Disease: Molecular Links & Clinical Implications
- (2008) Karen Neumann et al. Current Alzheimer Research
- Glycemic Control in Diabetes: A Tale of Three Studies
- (2008) Z. T. Bloomgarden DIABETES CARE
- More Choces Than Ever Before
- (2008) R. Keith Campbell et al. DIABETES EDUCATOR
- The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
- (2008) Su-Yen Goh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cognition and diabetes: a lifespan perspective
- (2008) Geert Jan Biessels et al. LANCET NEUROLOGY
- Metformin Protects the Brain Against the Oxidative Imbalance Promoted by Type 2 Diabetes
- (2008) Sonia Correia et al. Medicinal Chemistry
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now